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PRESENTATION OUTLINE
• Review of normal sleep physiology
• Neurocognitive effects of sleep disruption
• Common sleep disorders
• Insomnia




 Actigraphy ( Commonly used, developed in the early 1970s and has 
come into increasing use in both research studies and clinical practice; 
allows for the study of sleep-wake patterns and circadian rhythms via 
the assessment of body movements. The device is typically worn on 
the wrist and can easily be adapted for home use )
 Survey Instruments
 Many exist for detecting problematic sleep in children and adolescents, 
including self-report questionnaires ( such as the Child and Family 
Sleep History Questionnaire and the Pediatric Sleep Questionnaire 
(PSQ), sleep diaries, and parent report forms )

EEG SLEEP PATTERNS
Awake Low Voltage, Random, Fast
Drowsy 8-12 Hz, Alpha Waves
Stage 1 3-7 Hz, Theta Waves
Stage 2 12-14 Hz, Sleep Spindles and K-Complexes
Stage 3/4 0.5-2 Hz, Delta Waves, High Voltage, Slow Waves
REM Low Voltage, Random, Fast with Sawtooth Waves
NON-REM PHYSIOLOGICAL CHANGES
• Reduced physiological activity
• Autonomic slowing
• Maintain thermoregulation
• Episodic, involuntary movements
• Few rapid-eye movements
• Few penile erections/limited vaginal lubrication
• Reduced blood flow
REM PHYSIOLOGICAL CHANGES
• Increased physiological activity
• Autonomic activation
• Altered thermoregulation
• Partial or full penile erections/significant vaginal lubrication
• Skeletal muscle paralysis
• Rapid-eye movements
THE SLEEP CYCLE
 Cyclic nature of sleep is reliable
 Rapid eye movement (REM ) periods every  60 minutes      
(children ) & 90 minutes ( adults) 
 Most REM occurs earlier in sleep in younger children and  
later in adults 
 Stage 3 and REM decrease with age 
 Emergence of REM and non-rapid eye movement
(NREM ) sleep occur  over the first 3-6 months of age
 The 3 stages of NREM sleep ( N1,N2,N3) can be 
differentiated at 6 months of age













-Luteinizing hormone (LH) 
-Prolactin (PRL)
• Sleep  inhibits: 
-Adrenocorticotropic hormone (ACTH)




• Consolidation of learning and memory
• Immune system: The immune system also relies on 
sufficient quantity and quality of sleep and 
deficiency in sleep is linked to difficulty fighting 
infection and increased risk of sickness
• Growth and development: Stage N3 triggers the 
release of growth-promoting hormones, which 
boost muscle mass and repair cells and tissues in the 
body
SLEEP RECOMMENDATIONS FOR 
PEDIATRIC POPULATIONS: A consensus 
statement of the American Academy of Sleep Medicine 
Consensus recommendations* 
• Infants 4 months to 12: 12-16 hours per 24 hours (including naps)
• Children 1 to 2 years:  11-14 hours per 24 hours (including naps)
• Children 3 to 5 years:  10-13 hours per 24 hours (including naps)
• Children 6 to 12 years: 9-12 hours per 24 hours
• Teenagers 13 to 18 years:  8-10 hours per 24 hours
*Journal of Clinical Sleep Medicine, Vol. 12, No. 6, 2016
NEUROCOGNITIVE EFFECTS OF 
SLEEP DISRUPTION:
Studies show that short sleep in adolescents is associated with the following*:
• Poor school performance
• Obesity
• Metabolic dysfunction and cardiovascular morbidity




Insufficient sleep also is associated with an increased risk of motor vehicle accidents, which 
account for 35 percent of all deaths and 73 percent of deaths from unintentional injury in US 
teenagers. Research suggests that crash rates decline by 16.5 percent following a school 
start time delay of 60 minutes *
California Dreams Fulfilled for Teens: Governor Newsom signs SB328, the school start time 
bill; October 13,2019 https://www.startschoollater.net/press-releases/california-dreams-fulfilled-for-
teens-governor-newsom-signs-sb328-the-school-start-time-bill
*American Academy of Sleep Medicine April 14th, 2017
SLEEP DISORDERS IN CHILDREN
• Approximately 25% of children will suffer some type of sleep problem at 
some point during childhood.
• Complaints range from bedtime resistance and anxiety to primary sleep 
disorders, such as OSA and narcolepsy.
• Research is consistent with parents reporting 50% of preschool children, 
30% of school aged children, and 40% of adolescents as having sleep 
difficulties,
• Self-report among adolescents reveals 14 – 33% complaining of frequent 
or extended nighttime awakenings, Excessive Daytime Sleepiness (EDS) , 
unrefreshing sleep, early insomnia, and a subjective need for more sleep.
INTERNATIONAL CLASSIFICATION OF 
SLEEP DISORDERS -THIRD EDITION  
( ICSD-3 ) 
ICSD -3 has 7 major diagnostic detections 
• Insomnia
• Sleep-related breathing disorders 
• Central disorders of hypersomnolence 
• Circadian rhythm sleep-wake disorders 
• Parasomnias 
• Sleep-related movement disorders 
• Other sleep disorders 
NARCOLEPSY
• Irresistible bouts of sleep
• Cataplexy ( can be subtle in children, orofacial , with no clear 
association with emotions in comparison to adults ) 
• Sleep paralysis
• Hypnagogic or hypnopompic hallucinations and vivid dreams 
• Abnormal sleep-onset REM periods and disturbed nocturnal sleep
( sleep fragmentation ) 




 Cataplexy and REM related symptoms
 Selective serotonin reuptake inhibitors (SSRIs)
 Norepinephrine reuptake inhibitors (NRIs)
 Tricyclic antidepressants (TCAs )
 Monoamine oxidase inhibitors (MAOIs) 
 Gamma-hydroxybutyrate (GHB)
 Excessive daytime sleepiness
 Armodafinil and Modafinil  (Modafinil  is preferred in children: FDA-approved for children 
older than 17 years) 
 Amphetamines  (Methylphenidate is the second best in children) 
 Gamma-hydroxybutyrate (GHB)
NARCOLEPSY
 Gamma-hydroxybutyrate GHB ( Xyrem ) is the only 
FDA-approved medicine indicated for the treatment 
of both cataplexy or Excessive Daytime Sleepiness 
(EDS) in patients 7 years of age and older with 
narcolepsy
 Jazz Pharmaceuticals announced FDA Approval of 
Xyrem® (sodium oxybate) for the treatment of 
cataplexy or EDS in pediatric narcolepsy patients in 
Oct 29, 2018
INSOMNIA
The International Classification of Sleep Disorders –
Third Edition (ICSD-3) includes: 
• A report of sleep initiation or maintenance problems—
despite adequate opportunity and circumstances to sleep 
and with daytime consequences
• The ICSD-3 duration criterion for chronic insomnia disorder 
is 3 months, and a frequency criterion (at least 3 times per 
week) has been added
PEDIATRIC INSOMNIA 
Prevalence estimated at 1 – 6 % in general pediatric population but            
considerably higher amongst those children with neurodevelopment                
delay and chronic medical conditions
A study of 46 children (5-16 y/o) found that 50% of the those presenting 
to a pediatric sleep center for insomnia had another psychiatric  diagnosis. 
In  the remaining 50%, although parents denied any previous psychiatric 
history, 40% displayed psychiatric symptoms—documented by 
psychometric measures and clinical interviews—which suggests that 
comprehensive psychometric assessments are warranted in this 
population (Ivanenko et al. 2004; updated Alfano et al. 2009; Moturi et al. 
2010 )
BEHAVIORAL INSOMNIA
The child is unable to fall asleep and/or has prolonged nocturnal 
awakenings
There are 3 subtypes: 
1. The limit-setting type is demarcated by behaviors of stalling or 
refusing going to bed that are attributable to an inadequate limit 
setting by the parent or caregiver
2. The sleep-onset association type reflects the child’s dependency on 
a specific activity/behavior/ stimulation, typically objects or settings, 
for initiating sleep or returning to sleep following an awakening. 
When these are absent, sleep onset is significantly delayed
3. The mixed hybrid type is characterized by features of both sleep-
onset association difficulties and bedtime resistance
TREATMENT OF INSOMNIA (1) :  
SLEEP HYGIENE
• Identify the cause or other Axis I disorder (if possible) and treat
• Healthy sleep habits at night 
• Dedicate at least 30 minutes of wind-down time before bedtime in which you do 
something relaxing, such as read a book 
• Dim the lights in the house slightly for an hour or so before bed 
• Disconnect electronics: Stay away from light-emitting devices such as television, 
laptops, phones, and tablets—the blue light from their screens can alert the brain 
• Use the bed and bedroom for sleep and sex only
• Establish a regular pre-bedtime routine and a regular sleep/wake schedule
• Avoid alcohol or heavy meals too close to bedtime 
• Create a sleep-promoting environment that is dark, cool, and comfortable
• Avoid disturbing noises: consider a bedside fan or white-noise machine to block 
out disturbing sounds 
SLEEP HYGIENE (CONTINUED) 
• Observe healthy sleep habits during the day
• Avoid caffeine, particularly after noon
• Exercise regularly, earlier during the day, but not within the 3 hours 
before bedtime
• Avoid naps, particularly longer than 20 minutes and outside the 
1:00-3:oo PM time window. Keep a sleep diary to identify sleep habits 
and patterns that you can share with your doctor
COGNITIVE-BEHAVIORAL THERAPY 
TECHNIQUES SESSIONS (STANDARD)*
 Sleep restriction: Restrict actual time spent in bed to enhance and increase 
the homeostatic drive for sleep, enhance sleep depth and consolidation, 
improve sleep onset and maintenance
 Stimulus control therapy: Associate behaviors conducive to sleep with the 
activity of falling asleep, imprint bed and bedroom as sleep stimulus 
 Cognitive therapy: Address dysfunctional beliefs and attitudes about sleep
 Relaxation training: Decrease psychological and cognitive hyperarousal and 
anxiety
 Circadian rhythm entrainment: Reinforce or reset biological rhythm using 
light and/or chronotherapy
 Cognitive-behavior therapy : Combination of behavioral and cognitive 
approaches listed above
*J Clin Sleep Med 2008;4(5):487-504
COGNITIVE-BEHAVIORAL THERAPY 
TECHNIQUES SESSIONS (STANDARD)*
 Sleep restriction: Restrict actual time spent in bed to enhance and increase 
the homeostatic drive for sleep, enhance sleep depth and consolidation, 
improve sleep onset and maintenance
-Go to bed and wake up at the same time every day. Even if you have difficulties 
falling asleep and trouble awakening in the morning because you are tired, try to   
get up at the same time (weekends included). This can help adjust your body’s clock  
and aid in falling asleep at night. Go to bed  at the time you fall asleep and  
gradually reduce your sleep time to achieve your bedtime goals
 Stimulus control therapy: Associate behaviors conducive to sleep with the 
activity of falling asleep, imprint bed and bedroom as sleep stimulus 
- If unable to fall asleep within 20 minutes, get up and return to another space in the 
house to engage in a relaxing activity, such as reading or listening to music. You 
want bed to conjure sleepy thoughts and positive feelings only
TREATMENT OF INSOMNIA (2):  
MEDICATION
No FDA approved treatments
Sedatives are short-term solutions
A shorter half-life is typically preferred 
Alpha-2 agonists (clonidine, guanfacine) 
Sedating antihistamines (diphenhydramine, hydroxyzine, cyproheptadine) 
Benzodiazepines and similar agents(Sonata, Ambien, Lunesta)
Sedating antidepressants (trazodone, Remeron, low dose 1-3 mg doxepin  and TCAs)
Gabapentin  
Ramelteon (Rozerem) 
Other agents: Melatonin improves sleep latency  and sleep time by about 30 
minutes, prolonged release melatonin available with half life of 7 hours versus 30-50 
minutes in immediate release, 1-10 mg 30 minutes before bed to induce sleep and 
0.3-0.5 mg 4-5 hours before desired sleep time for circadian phase effect. Kava, 
valerian , L-tryptophan, chamomile, passion flower and lavender. 
INSOMNIA CASE
 Sam is a 12-year-old male with a childhood history of anxiety. He has a 
history of mild to moderate sleep disruption (primarily early and occasional 
middle insomnia) but over the past 6 weeks he has suffered increasing 
insomnia concurrent with an increase in school stressors. He presents to us 
with complaints of  going to bed at 11 p.m. on weekday and 12 a.m. on the 
weekends . He will lie in bed for 1-1.5 hours to fall asleep 4-5 x/ week  and 
will wake up  at 6 a.m. weekdays and 11 a.m. weekends. He will have nightly 
nocturnal awakenings  2-3 x/ week with difficulty falling back to sleep for up 
to  45 minutes. 
 How do we proceed ?
OBSTRUCTIVE SLEEP APNEA SYNDROME   
(OSA) 
 Prevalence is 1 %-4%
In prepubertal children, prevalence is equal in boys and girls. 
In adolescence, prevalence is higher in males
Habitual snoring occurs in 7-9 % of children at age 4-5 years and 5%                        
at age 10 years
More likely to present with ADHD symptoms  in children





• Excessive daytime sedation (typically more in adults than 
children )
• Poor academic performance
• Irritability
• Poor executive function
• Inattention/general cognitive impairment
INTERNATIONAL CLASSIFICATION OF 
SLEEP DISORDERS – THIRD EDITION  
(ICSD -3) 
The criteria for pediatric OSA have been simplified in the ICSD-3:
• Signs and symptoms are consolidated into a single criterion. One of 
these findings (snoring, labored/obstructed breathing or daytime 
consequences (sleepiness, hyperactivity, etc.)  must be present 
• The polysomnography (PSG) criterion for diagnosis requires: 
1. Either one or more obstructive events (obstructive or mixed apnea or 
obstructive hypopnea) per hour of sleep (Apnea–Hypopnea Index (AHI)
is an index used to indicate the severity of sleep apnea) or;
2. Obstructive hypoventilation, manifested by partial pressure of carbon 
dioxide (PaCO2) 50 mm Hg for 25% of sleep time, coupled with snoring, 
paradoxical thoracoabdominal movement or flattening of the nasal airway 
pressure waveform
OBSTRUCTIVE SLEEP APNEA (OSA) 
PEDIATRIC OBSTRUCTIVE SLEEP 
APNEA SYNDROME (OSA) SEVERITY
• AHI 1.5-4 and 86-91% oxygen desaturation: mild OSA 
• AHI 5-10 and 76-85% oxygen desaturation: mild to moderate OSA 
• AHI >10 and less than 75% oxygen desaturation: moderate to severe 
OSA 
OPTIONS INFORMED  BY 
SLEEP STUDY RESULTS 
• If AHI < 5
Watchful waiting or treat with anti-inflammatory agents like 
montelukast and intranasal steroids for 6 weeks 
• If AHI > 5
Tonsillectomy and Adenoidectomy (T&A) 
DIVING DEEPER: Rethinking AHI as the 
primary measure of OSA severity *
• In the study by Kainulainen et al. published by Journal of Clinical Sleep 
Medicine Agust,2019, the investigators assessed the correlation 
between excessive daytime sleepiness (EDS) and novel 
polysomnographic parameters, including obstruction duration, 
desaturation duration, desaturation severity, and obstructive severity
• Compared with the Apnea-Hypopnea Index (AHI) or oxygen 
desaturation index (ODI), the authors found a stronger correlation 
between EDS and these newer measures
• Although novel, these measures could be scalable
*Cielo CM, Tapia IE. Diving deeper: rethinking AHI as the primary measure of OSA severity. J Clin Sleep Med. 
2019;15(8):1075–1076
TREATMENT OF OBSTRUCTIVE 
SLEEP APNEA 
• Weight loss
• Tonsillectomy and Adenoidectomy (T & A)
• Success rate varies (59.8 %) based on curative AHI of less than 1
• High failure rate in obese patients, older than 7 years and with 
comorbid asthma/complex patients with dysmorphic features and 
genetic syndrome 
• CPAP (Continuous Positive Airway Pressure) prevents obstruction by 
soft-tissue and keeps airway open if significant residual sleep apnea
• Other surgical intervention (e.g. deviated septum, lingual tonsil)
• Avoid sedatives (which can prevent reawakening to breathe)
INTERNATIONAL CLASSIFICATION OF                   






-Sleep-related eating disorder 
• REM-related parasomnias
-REM sleep behavior disorder 
-Recurrent isolated sleep paralysis 
-Nightmare disorder 
Other parasomnias
-Exploding head syndrome 
-Sleep-related hallucinations 
-Sleep enuresis 
-Parasomnia due to a medical disorder
-Parasomnia due to a medication or substance 
- Parasomnia, unspecified 
NON-REM SLEEP PARASOMNIAS:
SHARED FEATURES
General criteria from the International Classification of Sleep Disorders for arousal disorders 
include:
(a) recurrent episodes of incomplete awakening
(b) absent or inappropriate responsiveness 
(c) limited or no cognition/ dream report 
(d) partial or complete amnesia for the episode 
(e) episodes typically occur several times per month
Typically in the first part of the night during slow wave sleep
Last 1 – 30 minutes
Retrograde amnesia
Family/personal history
More common in childhood
Attempts to awaken are fruitless




 Medications (Zolpidem /Ambien and other benzodiazepine receptor 
agonists (BZRAs), Tricyclic antidepressants (TCAs) and Lithium)
 Underlying sleep disorders like obstructive sleep apnea or restless legs 
syndrome
 Anxiety or stress
 Depression or other mental illness
 Nicotine, alcohol, and illicit drugs in older patients




 No gender differences noted
 17.3 % in children 3-13 years old
 Hallmarks include irrational acts, poor judgment, incoherence, and 
disorientation
 Complete amnesia
 Typically benign, although the occasional patient can become 
aggressive and violent 




 Prevalence 6-17% in children; lifetime prevalence is 18.3-40 %
 Prevalence 4.3 % in adults
 Can be coupled with enuresis
 No consistent gender differences
 Complete amnesia
 Sleepwalking meets the general criteria for NREM arousal disorders and is 
associated with ambulation 
 May engage in complex behaviors




 Prevalence 1–6.5% in children, 1–2.6% in adults
 Autonomic activation  (diaphoresis) 
 30 seconds – 3 minutes
 Subsequent lack of recall
 Gender preference
 Males more typically in childhood
 Females possibly more common in adulthood






Age at onset Any age Usually childhood
Frequency Nightly Several/month
Event onset Abrupt Gradual
Semiology Stereotyped; hypermotor 
features
Variable; no hypermotor 
features
Distribution Repetitive, clusters First 1/3 of night; isolated
Event duration < 1 minute (shorter) Several minutes (longer)
Sleep stage N2 > N3 N3
Natural history 70% respond to AEDs Spontaneous remission




 Avoid possible precipitants
 Treating an underlying sleep disorder (sleep apnea or restless legs 
syndrome)
 Behavioral modifications 
 Avoid sleep disruptions
 Loud noises, limit evening oral fluid intake
 Safeguard the home
 Movement sensors, locks on windows, remove potentially lethal 
objects, etc.
TREATMENT OF NON-REM 
PARASOMNIAS: MEDICATION
• There are no evidence-based treatment guidelines at present; 
however, low-dose medications have been used, especially if there 





• Selective serotonin reuptake inhibitors (SSRIs) and trazodone
ICSD-3 diagnostic criteria have been revised for many disorders. It is 
essential for sleep medicine physicians and other providers to familiarize 
themselves with these change (https://medicinainternaelsalvador.com/wp-
content/uploads/2017/03/internation-classification-ICSD-III-beta.pdf )
Use behavioral therapy to treat insomnia in combination with possible 
medications
Tonsillectomy and Adenoidectomy (T&A) results in reduction of AHI in 
children but a large percentage are not “cured”. Age, BMI, and co-morbid 
medical conditions are the best predictors of children that will not 
completely respond to T&A for OSA




1. Sleep Hygiene handout for patients and families 
http://www.cci.health.wa.gov.au/docs/Info-sleep%20hygiene.pdf
2. Pediatric Sleep questionnaire (PSQ) - American Thoracic Society
https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/psq.php  and 
http://www.mcbg.org/internal/services/sleep_center/documents/sleeppeds.pdf
3. CONTINUUM: Lifelong Learning in Neurology - LWW Journals
https://journals.lww.com/continuum/pages/default.aspx
4. Journal of Clinical Sleep Medicine (JCSM) 
http://jcsm.aasm.org
5. International Classification of Sleep Disorders-Third Edition Highlights and Modifications
https://medicinainternaelsalvador.com/wp-content/uploads/2017/03/internation-classification-ICSD-III-beta.pdf
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